salicylic acid has been researched along with Dermatitis Medicamentosa in 17 studies
Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 7.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
| "Ninety patients with alopecia areata were treated with weekly applications to one side of the head of dinitrochlorobenzene (DNCB) dissolved in acetone, the other side of the head serving as control region." | 7.66 | Dinitrochlorobenzene therapy for alopecia areata. ( Cebulla, K; Echternacht-Happle, K; Happle, R, 1978) |
| "Neonatal seizures are often refractory to treatment with initial antiseizure medications." | 5.40 | Levetiracetam-induced anaphylaxis in a neonate. ( Ariguloglu, EA; Koklu, E; Koklu, S, 2014) |
| "Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 3.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
| "Ninety patients with alopecia areata were treated with weekly applications to one side of the head of dinitrochlorobenzene (DNCB) dissolved in acetone, the other side of the head serving as control region." | 3.66 | Dinitrochlorobenzene therapy for alopecia areata. ( Cebulla, K; Echternacht-Happle, K; Happle, R, 1978) |
| "Succimer-treated children had an abrupt drop in blood lead level, followed by rebound." | 2.69 | Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group. ( , 2000) |
| "Imiquimod 5% cream is an immune-response-modifying drug with antiviral and anti-tumour activity." | 1.42 | Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome. ( Argenziano, G; Drummond, A; Lallas, A; Longo, C; Moscarella, E; Piana, S; Pichler, J; Zalaudek, I, 2015) |
| "Neonatal seizures are often refractory to treatment with initial antiseizure medications." | 1.40 | Levetiracetam-induced anaphylaxis in a neonate. ( Ariguloglu, EA; Koklu, E; Koklu, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, A | 1 |
| Hattori, M | 1 |
| Takeuchi, Y | 1 |
| Ishikawa, O | 1 |
| Manganoni, AM | 1 |
| Farisoglio, C | 1 |
| Ferrari, V | 1 |
| Zaniboni, A | 1 |
| Beretta, G | 1 |
| Meriggi, F | 1 |
| Calzavara-Pinton, P | 1 |
| TZANCK, A | 1 |
| SIDI, E | 1 |
| SHATIN, H | 1 |
| CANIZARES, O | 1 |
| WORTHINGTON, EL | 1 |
| Tavakkolizadeh, A | 1 |
| Povlsen, B | 1 |
| Giuffrida, R | 1 |
| Borgia, F | 1 |
| Cannavò, SP | 2 |
| Chiu, HY | 1 |
| Chiu, HC | 1 |
| Koklu, E | 1 |
| Ariguloglu, EA | 1 |
| Koklu, S | 1 |
| Drummond, A | 1 |
| Pichler, J | 1 |
| Argenziano, G | 1 |
| Zalaudek, I | 1 |
| Longo, C | 1 |
| Lallas, A | 1 |
| Piana, S | 1 |
| Moscarella, E | 1 |
| Guarneri, C | 1 |
| Osório, F | 1 |
| Magro, F | 1 |
| Lisboa, C | 1 |
| Lopes, S | 1 |
| Macedo, G | 1 |
| Bettencourt, H | 1 |
| Azevedo, F | 1 |
| Magina, S | 1 |
| Hagemann, T | 1 |
| Schlütter-Böhmer, B | 1 |
| Allam, JP | 1 |
| Bieber, T | 1 |
| Novak, N | 1 |
| Rodríguez-Martín, M | 1 |
| Sáez-Rodríguez, M | 1 |
| Carnerero-Rodríguez, A | 1 |
| Cabrera de Paz, R | 1 |
| Sidro-Sarto, M | 1 |
| Pérez-Robayna, N | 1 |
| Guimerá, F | 1 |
| Sánchez, R | 1 |
| García-Bustínduy, M | 1 |
| Noda-Cabrera, A | 1 |
| Happle, R | 1 |
| Cebulla, K | 1 |
| Echternacht-Happle, K | 1 |
| Strong, AM | 1 |
| Bracarda, S | 1 |
| Roila, F | 1 |
| Basurto, C | 1 |
| Tonato, M | 1 |
1 review available for salicylic acid and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
Topics: Adalimumab; Adult; Alopecia; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclona | 2012 |
1 trial available for salicylic acid and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group.
Topics: Chelating Agents; Child, Preschool; Drug Eruptions; Humans; Infant; Lead; Lead Poisoning, Nervous Sy | 2000 |
15 other studies available for salicylic acid and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Generalized keratosis pilaris-like eruptions in a chronic myelogenous leukemia patient treated with nilotinib.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Drug Eruptions; Female; Fusion Proteins, bcr | 2016 |
Multidisciplinary team-working indicators of good practice in the clinical management of EGFR-inhibitor dermatologic toxicities.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Er | 2009 |
[A case of paraamino-salicylic acid intolerance].
Topics: Aminosalicylic Acid; Drug Eruptions; Salicylic Acid | 1952 |
Lichen planus-like drug eruption due to para-amino salicylic acid; report of 5 cases, two showing mouth lesions.
Topics: Aminosalicylic Acid; Drug Eruptions; Humans; Lichen Planus; Mouth; Mouth Diseases; Salicylic Acid; T | 1953 |
A serious complication of topical wart treatment on the hand.
Topics: Administration, Topical; Antiviral Agents; Drug Eruptions; Hand Dermatoses; Humans; Male; Middle Age | 2004 |
Two cases of erosive pustular dermatosis of the scalp occurring after topical 3.75% imiquimod for actinic keratoses.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Clobetasol; Dermatologic Agents; Drug Eruptions; | 2019 |
Scalp pustules in a patient receiving chemotherapy.
Topics: Acneiform Eruptions; Aged; Aged, 80 and over; Biopsy; Drug Eruptions; ErbB Receptors; Erlotinib Hydr | 2013 |
Levetiracetam-induced anaphylaxis in a neonate.
Topics: Anaphylaxis; Anticonvulsants; Asphyxia Neonatorum; Contraindications; Drug Eruptions; Exanthema; Fac | 2014 |
Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.
Topics: Alopecia; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Drug Eruptions; Female; | 2015 |
Erosive pustular dermatosis of the scalp from topical minoxidil 5% solution.
Topics: Aged; Alopecia; Dermatologic Agents; Drug Eruptions; Female; Humans; Minoxidil; Scalp; Scalp Dermato | 2013 |
Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
Topics: Administration, Topical; Aged; Alopecia; Dermatitis, Allergic Contact; Drug Eruptions; Female; Human | 2005 |
Pustular allergic contact dermatitis from topical minoxidil 5%.
Topics: Adult; Dermatitis, Allergic Contact; Drug Eruptions; Forehead; Humans; Male; Minoxidil; Scalp; Vasod | 2007 |
Dinitrochlorobenzene therapy for alopecia areata.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Child; Dinitrochlorobenzene; Drug Eruptions; Female; Human | 1978 |
Extensive cicatrical alopecia following scalp vein infusion.
Topics: Adolescent; Alopecia; Bicarbonates; Cicatrix; Drug Eruptions; Fluid Therapy; Humans; Male; Scalp | 1979 |
Inflammatory reaction presages response in melanoma skin lesions during i.m. rIFN alpha-2a-based treatment.
Topics: Adult; Drug Eruptions; Humans; Injections, Intramuscular; Interferon alpha-2; Interferon-alpha; Male | 1990 |